Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Mar 27, 2018 2:57pm
130 Views
Post# 27788940

RE:From Dr Mandel to us!!!!

RE:From Dr Mandel to us!!!!4 for 4, yaz, is that 100%?? 

4 for 4, primary, safety and tolerability achieved!!! Is that 100 %, yaz?

4 for 4,  Secondary pharmacokinetics achieved!!!! Yaz, is that 100%?

AND HERE IS THE BIG ONE YAZ!!!!!!!!!!!!

4 FOR 4, EXPLORATORY , EFFICACY ACHIEVED IN PHASE 1, YAZ!!! IS THAT 100%, YAZ???

GEE, COULD THOSE RESULTS BE ANY BETTER??? WELL YES, THEY COULD HAVE BEEN CURED, RIGHT???

SOON, YAZ, SOON!!!!!!!!!!!!!!!!!!!

GO JV, GO
MTGA, DO A DUBE! 


macman1519 wrote:
Read below from the presentation. 
EFFICACY ACHIEVED IN FIRST FOUR IN PHASE ONE!! 
CAN U READ THAT YAZ, NEED AN EXPLAINATION OF WHAT EFFICACY MEANS, YOU CLUELESS SCUMMIE??? 


Light activated Photo Dynamic Compound (“PDC”) (TLD-1433) used clinically in first 3 patients in a Phase 
Ib NMIBC clinical study, at the Maximum Recommended Starting Dose (“MRSD”) (0.35 mg/cm2
) achieving 
the following outcome measures:
1) Primary (Safety and Tolerability) (at 180 days post-treatment)
2) Secondary (PharmacoKinetics (“PK”) (movement and exit of drug within tissue)) (at 180 days post-b
treatment)
3) Exploratory (Efficacy, as measured by Recurrence Free-Survival (“RFS”)) (at 90 days post-treatment)
4th patient treated at the Therapeutic Dose (0.70 mg/cm2
) has achieved the primary, secondary and 
exploratory outcome measures (at 90 days post-treatment). 5th and 6th patient clinical data pending


Bullboard Posts